Intraductal papillary mucinous neoplasm (IPMN) with low- or intermediate-grade dysplasia
Pancreas
Definition
An intraductal benign epithelial neoplasm arising from the main pancreatic duct or its major branches. Signs and symptoms include epigastric pain, weight loss, jaundice, diabetes, and pancreatitis. It is composed of columnar mucin-containing cells which line dilated ducts and form papillary or pseudopapillary structures. Dysplastic changes in the columnar cells are minimal or absent. The prognosis is usually favourable.
Proposed definition:
Intraductal papillary mucinous neoplasms (IPMNs) are intraductal grossly-visible (typically ≥ 1.0 cm) epithelial neoplasms of mucin producing cells, arising in the main pancreatic duct or its branches 
Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Kloppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus GJ, Shimizu M, Yonezawa S (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28: 977-87

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S, (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6: 17-32
. Signs and symptoms include epigastric pain, weight loss, jaundice, diabetes, and pancreatitis. The neoplastic epithelium is usually papillary, and the degrees of mucin secretion, duct dilatation (cyst formation), and dysplasia are variable. IPMNs are classified on the basis of the highest degree of cytoarchitectural atypia and invasiveness as:
> IPMN with low- to intermediate-grade of dysplasia, previously called intraductal papillary-mucinous adenoma
> IPMN with high grade of dysplasia
, previously called intraductal papillary-mucinous carcinoma, non-invasive
> IPMN with an associated invasive carcinoma
if there is a component of invasive carcinoma.
In case of IPMN with low- to intermediate-grade of dysplasia, dysplastic changes in the columnar cells are minimal or absent. The prognosis is usually favourable.
Commentary: Preneoplastic lesions of the digestive system
|
Contributors:
Volkan N. Adsay
Volkan N. Adsay Department of Pathology Emory University Hospital Atlanta USA
Giuseppe Zamboni
Giuseppe Zamboni Department of Pathology University of Verona, Ospedale Sacro Cuore-Don Calabria Negrar-Verona Italy
Noriyoshi Fukushima
Noriyoshi Fukushima Department of Pathology Jichi Medical University Tochigi Japan
Toru Furukawa
Toru Furukawa Institute for Integrated Medical Sciences Tokyo Women’s Medical University Tokyo Japan
Ralph H. Hruban
Ralph H. Hruban Department of Pathology Johns Hopkins Medical Institutions Baltimore USA
David S. Klimstra
David S. Klimstra Department of Pathology Memorial Sloan-Kettering Cancer Center New York USA
Günter Klöppel
Günter Klöppel Department of Pathology Technical University of Munich München Germany
Johan A. Offerhaus
Johan A. Offerhaus Department of Pathology University Medical Center Utrecht Utrecht THE NETHERLANDS
Martha Bishop Pitman
Martha Bishop Pitman Department of Pathology Harvard Medical School, Massachusetts General Hospital Boston USA
Michio Shimizu
Michio Shimizu Department of Pathology Saitama International Medical Center Saitama Japan
|